Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

An Analysis on Prescribing Patterns of Antidepressants and Their Associated Factors in Lung Cancer Patients

폐암 환자의 항우울제 처방현황과 관련 요인 분석

  • Received : 2016.05.02
  • Accepted : 2016.06.14
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Depression is the leading cause of lowering the quality of life of cancer patients and lung cancer is the most likely to cause depression. It is necessary to find out depression-related factors in lung cancer patients. Methods: The study was a retrospective cohort study using medical records, and was a non-equivalent comparison group design. It involved patients diagnosed of lung cancer at the Konkuk University Medical Center from January to December 2012. Between antidepressants prescription group and non prescription group, socio-demographic factors, clinical factors, treatment-related factors and other factors were analyzed statistically. Results: Antidepressant prescription group consisted of 23 people and non-prescription group of 206 people. Prescription rate of quetiapine was the highest 47.8% (11/23), followed by escitalopram (43.5%, 10/23), amitryptyline and trazodone (30.4%, 7/23). The prescription group was prescribed with an average of 1.9 antidepressants. Antidepressants were prescribed after average of 248 days from lung cancer diagnosis and prescription period per patient was average 177.5 days. According to the result of univariate logistic regression analysis between 2 groups, factors such as number of outpatient visit, number of admission, days of hospitalization, sleep disorder, and comorbidity were found to be statistically significant (p < 0.05). However, According multivariate logistic regression analysis showed that number of admission, days of hospitalization and sleep disorder were statistically significant (p < 0.05) excluding comorbidity. Conclusion: About 10% of lung cancer patients had received a prescription for antidepressants after lung cancer diagnosis. A sleep disorder, number of hospitalization and length of stay were identified as factors influencing the prescribing antidepressants.

Keywords

References

  1. Statistics Korea. Available from http://kosis.kr./wnsearch/totalSearch.jsp. Accessed January 14, 2016.
  2. Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015 Apr; 47(2):127-41.
  3. National Cancer information center. Available from http://www.cancer.go.kr/mbs/cancer. Accessed January 14, 2016.
  4. Smith E, Gomm S, Dickens C. Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med 2003;17(6):509-13. https://doi.org/10.1191/0269216303pm781oa
  5. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliativecare settings: a meta-analysis of 94 interview-based studies. The Lancet Oncol 2011;12(2):160-74. https://doi.org/10.1016/S1470-2045(11)70002-X
  6. Devlen J, Maguire P, Phillips P, et al. Psychological problems associated with diagnosis and treatment of lymphomas. I: retrospective study. Br Med J (Clin Res Ed) 1987;295(6604):953. https://doi.org/10.1136/bmj.295.6604.953
  7. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;(32):57-71.
  8. Cavu o lu H. Depression in children with cancer. J Pediatr Nurs 2001;16(5):380-5. https://doi.org/10.1053/jpdn.2001.0000
  9. Carlson LE, Bultz BD. Cancer distress screening: needs, models, and methods. J Psychosom Res 2003;55(5):403-9. https://doi.org/10.1016/S0022-3999(03)00514-2
  10. Goldzweig G, Meirowitz A, Hubert A, et al. Meeting expectations of patients with cancer: relationship between patient satisfaction, depression, and coping. J Clin Oncol 2010;28(9):1560-5. https://doi.org/10.1200/JCO.2009.25.4987
  11. Pinquart M, Duberstein P. Depression and cancer mortality: a metaanalysis. Psychol Med 2010;40(11):1797-810. https://doi.org/10.1017/S0033291709992285
  12. Lee JL, Kim KS. The relationships between stigma, distress, and quality of life in patients with lung cancer. J Korean Oncol Nurs 2011;11(3):237-46. https://doi.org/10.5388/jkon.2011.11.3.237
  13. Sellick SM, Edwardson AD. Screening new cancer patients for psychological distress using the hospital anxiety and depression scale. Psycho-Oncology 2007;16(6):534-42. https://doi.org/10.1002/pon.1085
  14. Walker J, Sawhney A, Hansen CH, et al. Treatment of depression in people with lung cancer: a systematic review. Lung Cancer 2013;79(1):46-53 https://doi.org/10.1016/j.lungcan.2012.09.014
  15. Anatomical-Therapeutic-Chemical-Classification-System. ATC/DDD Index 2013. Available from: http://www.whocc.no/atc_ddd_index. Accessed May 14, 2014.
  16. Loy JW, McPherson BD, Kenyon GS. Sport and social systems: a guide to the analysis, problems, and literature: Addison-Wesley Reading, MA; 1978.
  17. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatmentmeta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160(14):2101-7. https://doi.org/10.1001/archinte.160.14.2101
  18. Statistics-Korea. Cancer Registration Statistics 2010. Available from: http://kosis.kr/gen_etl. Accessed May 14, 2014.
  19. Min KJ, Kwon JS, Kim W, et al. Korean clinical practice guideline of depressive disorders. Korean J Biol Psychiatry 2006;13(1):16-8.
  20. Bauer M1, Monz BU, Montejo AL, et al. Prescribing patterns of antidepressants in Europe: results from the factors influencing depression endpoints research (FINDER) study. Eur Psychiatry 2008 Jan;23(1):66-73.
  21. Park JH, Lee JJ, Lee SB, et al. Prevalence of major depressive disorder and minor depressive disorder in an elderly Korean population: results from the Korean longitudinal study on health and aging (KLoSHA). J Affect Disord 2010;125(1-3):234-40. https://doi.org/10.1016/j.jad.2010.02.109
  22. Djernes J. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006;113(5):372-87. https://doi.org/10.1111/j.1600-0447.2006.00770.x
  23. Cataldo JK, Slaughter R, Jahan TM, et al. Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum 2011;38(1): E46-54. https://doi.org/10.1188/11.ONF.E46-E54
  24. Kitagawa R, Yasui-Furukori N, Tsushima T, et al. Depression increases the length of hospitalization for patients undergoing thoracic surgery: a preliminary study. Psychosomatics 2011;52(5):428-32. https://doi.org/10.1016/j.psym.2011.03.010
  25. Vena C, Parker KP, Allen R, et al. Sleep-wake disturbances and quality of life in patients with advanced lung cancer. Oncol Nurs Forum 2006;33(4):761-9. https://doi.org/10.1188/06.ONF.761-769
  26. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000;18(4):893-903. https://doi.org/10.1200/JCO.2000.18.4.893
  27. Tanaka K, Akechi T, Okuyama T, et al. Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else? J Pain Symptom Manage 2002;23(6):490-500. https://doi.org/10.1016/S0885-3924(02)00400-1
  28. Lee GH, Oh EH. Effect of guided imagery program on patients depression and anxiety receiving cancer chemotherapy. J Korean Acad of Psychiatr Ment Health Nurs 2004;13(2):125-34.
  29. Toh S, Rodríguez LA, Hernandez-Diaz S. Use of antidepressants and risk of lung cancer. Cancer Causes Control 2007 Dec;18(10):1055-64. https://doi.org/10.1007/s10552-007-9045-1
  30. Sullivan DR1, Ganzini L2, Duckart JP, et al. Treatment receipt and outcomes among lung cancer patients with depression. Clin Oncol 2014 Jan;26(1):25-31. https://doi.org/10.1016/j.clon.2013.09.001